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QUESTING ONE BRAZILIAN QUERY: REPORTING 16 CASES OF Q FEVER
FROM MINAS GERAIS, BRAZIL
Paulo Sérgio Gonçalves da COSTA(1,2), Marco Emilio BRIGATTE(2) & Dirceu Bartolomeu GRECO(1)
SUMMARY
Q fever has been considered non-existing in Brazil where reports of clinical cases still cannot be found. This case-series of 16
patients is a result of a systematic search for such illness by means of clinical and serologic criteria. Serologic testing was
performed by the indirect microimmunofluorescence technique using phase I/II C. burnetii antigens. Influenza-like syndrome was
the most frequent clinical form (eight cases - 50%), followed by pneumonia, FUO (fever of unknown origin), mono-like syndrome
(two cases - 12.5% each), lymphadenitis (one case - 6.3%) and spondylodiscitis associated with osteomyelitis (one case - 6.3%).
The ages varied from four to 67 years old with a median of 43.5. All but one patient had positive serologic tests for phase II IgG
whether or not associated with IgM positivity compatible with acute infection. One patient had both phase I and phase II IgG
antibodies compatible with chronic Q fever. Seroconvertion was detected in 10 patients. Despite the known limitations of serologic
diagnosis, the cases here reported should encourage Brazilian doctors to include Q fever as an indigenous cause of febrile illness.
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INTRODUCTION
Coxiella burnetii is a Gram-negative bacterium, intracellular
obligate, former Rickettsiae now belonging to the Legionellacea family
of the γ group of proteobacteria2,7,12. It is the etiologic agent of a
worldwide human infection named Q fever2,11,12, a disease initially
described in Australia by Derrick (1935) and so nominated “Query
fever”, giving its enigmatic etiologic nature at that time11.
The infection occurs in a zoonotic cycle involving several mammals
and birds species2,11,12. Arthropod vectors have been considered
important in animal but not in human transmission11,12 and human
infections occur mainly by contaminated dust inhalation, infected
tissues manipulation or raw milk ingestion2,11,12. Cattle, goats and sheep
have been frequently linked to rural C. burnetii infections2,11,12 but dog
and cat-associated Q fever have been described in both urban and rural
areas15.
C. burnetii can be transported by the wind and infected people
sometimes never recall direct contact with animals11,12,21 and such
unusual fitness along the very small number of bacteria required for
infection makes this agent eligible for biological warfare2. Since C.
burnetii does not yield in standard culture medium7,12 the laboratory
diagnosis relies mostly on serological tests2,4,5,7,11,12 not routinely
available in developing countries. Fortunately, most human infections
are asymptomatic or mild11,12 resembling a self-limited influenza, but
hepatitis, pneumonia and the so-called chronic Q fever, associated or
not with endocarditis, can have severe outcomes if not properly
treated2,7,11,12,16. Newly described syndromes such as Q fever in
pregnancy, chronic vascular graft infection, myocarditis, pericarditis,
osteomyelitis, cholecystitis, pancreatitis and meningitis reinforce the
need of proper identification of C. burnetii infections everywhere8,12,16.
C. burnetii infections are supposed to occur throughout the world
but reports from South America have been deemed scarce13,22. The more
recent published Brazilian serologic survey for Q fever backs 197518
and published case reports remain to be found so the aim of this
publication is to report 16 cases of Q fever serologically and clinically
diagnosed.
PATIENTS AND METHODS
From January 2001 to June 2004, 726 febrile patients were screened
for rickettsial infections as part of a specific protocol for etiologic
investigation3. These patients were seen in five different health care
services from Juiz de Fora city, Minas Gerais State, Brazil. They were
classified into different clinical syndromes according to their symptoms
and signs and current diagnostic criteria3. Serum samples were tested by
indirect microimmunofluorescence technique as described elsewhere14
with phase I and phase II C. burnetii (Nine Mile strain) antigens. Serologic
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testing for other rickettsial agents were also performed using the following
antigens: Rickettsia typhi (Wilmington strain), Rickettsia rickettsii (Sheila
Smith strain), Bartonella henselae (Vero cells-Houston strain), Bartonella
quintana (Vero cells) and Ehrlichia chaffeensis (DH 82 infected cells -
Arkansas strain). Viral and Rickettsial Branch of CDC Atlanta USA
provided all antigens and control sera. Fluorescein-conjugated goat anti-
human IgG and IgM (BioMérieux) obtained commercially were used
for antibody detection. All samples were collected during the
symptomatic phase of the disease and whenever possible convalescent
samples (two to four weeks apart) were additionally collected. Serum
samples were initially screened at the dilution of 1:64 and those positive
were subsequentially titered to the end-point considered the final titer.
The slide readings were done blindly and a fluorescence of at least 2+
was required for positivity. Rheumatoid factor absorption was not
performed but the tested samples were directly checked for the presence
of rheumatoid factors (Latex agglutination and Waaler-Rose test).
Extensive array of laboratory tests such as blood cell counts, biochemical
analysis, blood cultures and serologic assays for Mycoplasma pneumonia,
Chlamydia pneumoniae, Leptospira interrogans, Brucella spp.,
Salmonella, EB virus, CMV, Toxoplasma gondii, Treponema pallidum
and dengue fever were performed in referral commercial laboratories.
Other tests like those for parvovirus B19, Lyme disease, schistosomiasis,
American trypanosomyasis and influenza were performed in some but
not all patients.
Current serologic criteria for Q fever diagnosis2,4,5,7,12 were used:
anti-phase II C. burnetii IgG and/or IgM seroconvertion - confirmed7,11;
IgG ≥ 1:256 and/or IgM ≥ 1:64 - probable (sensitivity 58.4% -
specificity 92.2%7); IgG ≥ 1:128 and or IgM ≥ 1:32 - possible2. For
seroconvertion IgG and or IgM negative to positive the cut-off values
were respectively 1:64 and 1:327,12. The absence of seroconvertion
between acute and convalescence samples precluded the serologic
diagnosis. Anti-phase I C. burnetii IgG ≥ 1:800 associated or not with
anti-phase II C. burnetii antibodies were considered for chronic Q fever
diagnosis (sensitivity 100% - specificity 98.6%7).
RESULTS
Twelve out 16 patients (75%) were males and the age varied from
four to 67 years old with a median of 43.5 years old. Three cases
(18.8%) occurred in children. The fever median duration time was
10.5 days varying from two to 20 days. Twelve patients corresponding
to 75% reported frequent animal contact but just seven (43.7%) came
from rural areas (data not shown). Influenza-like syndrome was the
most frequent diagnosis with eight cases (50%) followed by pneumonia,
FUO and mono-like syndrome with two cases (12.5%) each.
Lymphadenitis (one case - 6.3%) and spondylodiscitis associated with
osteomyelitis (one case - 6.3%) completed the series.
All patients recovered either with (10 cases - 62.5%) or without
(six cases - 37.5%) proper therapy. Gatifloxacin was antimicrobial
agent used in six cases, ciprofloxacin in two cases and doxycyclin
plus ciprofloxacin plus hydroxychloroquine in one case
(spondylodiscitis associated with vertebral osteomyelitis).
Seroconvertion was observed in 10 cases (62.5%) and these were
considered confirmed. Four cases had serologic findings in isolated
samples compatible with probable acute Q fever and two cases with
possible acute Q fever. All but one case had compatible IgM serologic
response detected. High IgG titers for phase I and phase II C. burnetii
antigens were detected in a case of spondylodiscitis/osteomyelitis
compatible with chronic Q fever3,7,12. Cross-reactivity with other
rickettsial agents was detected in five cases (31.2%), and all patients
had some degree of cross-reactivity between phase I and phase II C.
burnetii antibodies. Extensive cross-reactivity with R. rickettsii and R.
typhi associated with IgG seroconvertion was observed in one case but
IgM seroconvertion exclusively to C. burnetii suggested Q fever
diagnosis. Rheumatoid factor however was detected in this case.
Increased CRP was observed in all cases ranging from 12 to 90 mg
and leukocyte counts ranged from 3.5 to 14 x 103 /mm3. Slightly
increased AST and ALT (less than three times the higher normal value)
was detected in 10 cases (62.5%).
Table 1 shows the demographics, clinical and serologic findings of
the reported cases.
DISCUSSION
Although considered a worldwide zoonosis, published human cases
of Q fever from Brazil remain to be found. Extensive search in Index
Medicus, Lilacs, PubMed, MEDLINE and other Internet search
machines did not find any reference to the isolation of this agent from
clinical samples in Brazil but at least one Brazilian group has been
studying experimental C. burnetii infection23. Nevertheless serosurveys
were reported in the past when RIBEIRO-NETO et al.17 carried out the
pioneering studies in the state of São Paulo founding a seroprevalence
rate of 8.5% among 200 dairy farm workers as compared with 0.47%
among 212 urban industry employees. Ten years later, RIEMANN et
al. observed an infection rate of 22% among 219 veterinary personnel19
and of 29% among 144 slaughterhouse employees18 in the Minas Gerais
State capital, Belo Horizonte. Recent serosurvey in the Piau county,
Minas Gerais State, found a 3.9% seropositivity rate among healthy
population3. These data despite their limitations suggest the presence
of C. burnetii in Brazil but for some reason Q fever, reported southern20
and northern of Brazil22 has remained forgotten in this Country.
The majority of cases here reported had influenza-like symptoms
and the most frequent clinical presentations of Q fever have been both
influenza-like syndrome and intermediate duration undifferentiated
fever2,11,12.
Two cases of pneumonia were identified as being caused by C.
burnetii in this series and pneumonia is one classical form of Q
fever2,7,12,16. Contrarily to the previously thought11, alveolar infiltrates
indistinguishable from other bacterial pneumonia is the most common
pattern1,12,16 as observed in the cases reported here.
Hepatic attack in the form of granulomatous hepatitis has been
classically associated to Q fever2,7,11,12 but the only liver abnormality
detected in the cases of this series was slightly increased AST/ALT in
some but not all patients. Asymptomatic liver attack characterized by
increased AST/ALT moreover is a very common pattern in Q fever12.
Two cases here reported had lymphadenitis resembling cat scratch
disease, a syndrome that has been not frequently linked to C. burnetii
infections11,12. Recent evidences however suggests that this presentation
can be far more common than previously thought6.
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FUO cases were described in this series and such clinical syndrome
has been associated with both acute and chronic Q fever. The former has a
pattern of fever of intermediate duration associated with influenza-like
symptoms12 and the last with either multisystemic disease or endocarditis12.
Two cases of mono-like syndrome were identified in this series
and C. burnetii usually does not appear as causing such syndrome8,12.
Superposing symptoms between mono-like syndrome, FUO and
influenza-like syndrome might be hiding the real occurrence of the
former.
A wide range of osteoarticular manifestations has been recently
associated with C. burnetii infections and spondylodiscitis associated
with vertebral osteomyelitis as in one case here reported, has been one
of them12,16. Such infections have the tendency of chronicity and demand
long-term specific therapy12,16.
Most of the cases here reported fit with acute Q fever, which is the
most prevalent form of this infection2,7,11,12. Contrarily to acute Q fever,
which has a benign course, chronic Q fever is a severe disease difficult
to treat and associated with bad outcomes2,11,12,16. Chronic pulmonary
infiltrates associated or not with infective endocarditis is the most
frequent clinical scenario in chronic Q fever11,12,16. Recent reports of
chronic Q fever causing vascular grafts infections, osteomyelitis and
chronic fatigue syndrome2,7,8,12,16, all long-lasting conditions, demand
changes in our paradigms about this outstanding infectious agent.
Animal contact was reported by most of the patients in this series
but many of them came from urban areas. Q fever is no longer
considered an exclusively rural zoonosis and urban outbreaks have
been reported12,15. A recent outbreak in French Guyana found an urban
rather than rural pattern of infection distribution22 and the former idea
of rural zoonosis has been replaced by “everywhere zoonosis” given
the multiple ways of transmition of C. burnetii, an expected
consequence of its powerful fitness and infectivity2,11,12.
Most of the cases here reported occurred in males and this is an
expecting and frequently reported finding considering the outdoor
activities and closer contact with animals associated with this gender2,12.
The possible protective role of estrogens against C. burnetii infection
however could be an alternative explanation10.
Only few patients in this series were children. Q fever has been
labeled as a disease of adults, especially because the increased outdoors
activities of this group but Q fever in infancy is well known and the
clinical picture quite similar11.
Increased CRP as observed in all cases of this series has been a
common finding in Q fever12 and considered a useful tool especially
for the differential diagnosis with viral infections12. Leukocyte counts
within normal range or slight leukocytosis has been also commonly
found in Q fever as in the cases here reported11,12.
 Table 1
Clinical, laboratory, and demographic data of Q fever cases (C. burnetii)
Patient 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Diagnosis Co Co Co Co Co Co Co Co2 Co Co Pr Pr Pr Pr Ps Ps
Age 39 34 45 12 47 20 23 67 46 67 4 42 46 4 55 48
Sex M M F F M F M M M M M M M M F M
Clinical form In In Pn1 In In Pn1 In Fu3 M Sd La In Fu In Ml In
Days of fever 15 10 3 17 15 4 10 14 20 5 4 3 18 2 12 11
Therapy N N G G G G G C D D N G N A N N
C. burnetii I IgG 1:128 1:1024 1:64 1:64 1:1024 1:64 1:32 1:2048 1:256 1:1024 1:64 1:256 1:512 1:512 1:32 1:64
C. burnetii I IgM 1:64 1:1024 1:64 1:64 1:64 1:64 1:64 1:2048 1:128 1:2048 1:128 1:32 1:64 1:512 1:16 1:32
C. burnetii II IgG 1:1024 1:1024 1:64 1:256 1:1024 1:64 1:32 1:2048 1:256 1:1024 1:256 1:256 1:512 1:512 1:128 1:128
C. burnetii II IgM 1:64 1:1024 1:128 1:128 1:64 1:64 1:128 1:2048 1:128 1:1024 1:128 1:32 1:64 1:512 1:32 1:32
B. henselae IgG - - - - 1:64 - - - - - 1:64 - - - - -
B. henselae IgM - - - - 1:64 - - - - - - - - - - -
B. quintana IgG - - - - 1:64 - - - - - 1:64 - - - - -
B. quintana IgM - - - - - - - - - - - - - - - -
R. rickettsii IgG - - - - - - - 1:2048 - 1:64 - - - - - -
R. rickettsii IgM - - - - - - - - - - - - - - - -
R. typhi IgG - - 1:32 - - - - 1:2048 - - - - - - - -
R. typhi IgM - - 1:16 - - - - - - - - - - - - -
E. chaffeensis IgG - - - - - - - - - - - - - - - -
E. chaffeensis IgM - - - - - - - - - - - - - - - -
Seroconvertion Y Y Y Y Y Y Y Y Y Y N N N N N N
Rheumatoid factor N N NT N N N N Y N N N N NT N N N
Leukocyte count 103 6 5.5 11 8 8 7 9 14 12 9 13 7 6 3.5 8 11
Increased AST/ALT Y N N Y Y N Y Y Y N N N Y Y Y Y
CRP 23 30 45 37 18 28 31 90 30 50 40 12 20 26 19 15
Epidemiology Y Y Y N Y N Y N Y N Y Y Y Y Y Y
Outcome R R R R R R R R R R R R R R R R
M = male; F = female; N = no; Y = yes; Co = confirmed; Pr = probable; Ps = possible; - = negative; G = gatifloxacin; C = chloramphenicol; D = doxycyclin; A =
azythromycin; R = recovery; CRP = C reactive protein; In = influenza-like; La = lymphadenitis; Pn = pneumonia; FU = FUO; Ml = mono-like; Sd = spondylitis plus
vertebral osteomyelitis; 1 = lobar infiltrate; 2 = rheumatoid factor positive; 3 = echocardiogram suspected of endocarditis (mural vegetation).
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All patients recovered either with or without therapy and this is
the most common pattern of acute Q fever considered a benign and
self-limited disease2,7,11,12. New generation quinolones have been a good
option for suspected cases and especially useful for therapeutic
approach in cases of pneumonia1,12. Chronic Q fever on the other hand
requires long-term combined therapy and doxycyclin associated with
ciprofloxacin and chloroquine, the last promoting alkalinization of
phagolysosome, are supposed to be effective12,16.
All cases here reported had serologically diagnosed Q fever
according to current criteria2,4,5,7,12,16 and from the practical standpoint
serology, especially immunoflourescence, is a well-established way
for such diagnosis2,7,12. High titers IgG antibodies to phase II antigens
associated or not with IgM antibodies are characteristically
representative of acute Q fever while the presence of IgG phase I
antibodies alone or associated with anti IgG phase II antigens suggests
chronic Q fever2,4,7,12,16.
 As in other rickettsial infections, cross-reactivity has been
frequently an important obstacle for serologic tests4,5,7,12 but this aspect,
with one exception, was not prominent in this series. The presence of
rheumatoid factor could be an additional explanation7 for the extensive
cross-reactivity in that particular case. Extensive cross-reactivity
between phase I and phase II C. burnetii antibodies was observed here
and this is a well-known phenomenon, possibly resulting from antigenic
similarities between these antigens4,5,7,12. The most troublesome aspects
of serology in this sense are the cross-reactivity with Chlamydia,
Legionella and Bartonella spp.9,12,13 all causative agents of very close
clinical syndromes. Other rickettsial agents are also prone in inducing
cross-reactivity with C. burnetii usually in lower titers4,5,7,12 as observed
in some cases here reported.
Far more sophisticated and reliable tests such as cell culture, PCR
and immunohistochemical also could be used for diagnostic purposes
in Q fever but these are expensive, have low sensibility once set the
antibody response, and are not readily available7,12.
The data presented here has shown clinical and serologic evidences
of symptomatic human C. burnetii infection in Brazil making important
to consider Q fever among the infectious syndromes occurring in the
region. Actually, they represented 2.2% of the etiologies in 726 febrile
patients from that region3. Given the unique laboratorial requirements
for such diagnosis and the uncharacteristic clinical aspects, Q fever
cases might have been overlooked and despite the usually favorable
outcome, specific treatment has been required sometimes thus making
the questing for the proper diagnosis necessary2,12,16. Given the known
limitations of serologic tests and the uncharacteristic clinical findings,
more specific and sophisticated methods should be used in the future
to access this exquisite infection.
RESUMO
Investigando uma interrogação brasileira: relatando 16 casos de
febre Q em Minas Gerais, Brasil
A febre Q continua sendo considerada inexistente no Brasil onde
publicações de casos clínicos ainda não são encontráveis. Esta série de
casos de 16 pacientes é resultado de uma busca sistemática para esta
doença usando-se critérios clínicos e sorológicos. Os testes sorológicos
foram realizados pela técnica de microimunofluorescência indireta
utilizando-se antígenos de C. burnetii fase I e fase II. Síndrome
influenza símile foi a forma clínica mais frequente (oito casos - 50%),
seguida pela pneumonia, FOI (febre de origem indeterminada),
síndrome mononucleose símile (dois casos - 12,5% cada) e por fim
linfoadenite (um caso - 6,3%) e espondilodiscite associada à
osteomielite (um caso - 6,3%). As idades variaram de quatro a 67 anos
com mediana de 43,5. Todos os pacientes, com exceção de um, tinham
testes sorológicos positivos para IgG anti fase II, associado ou não a
IgM anti fase II, compatíveis com infecção aguda. Um paciente tinha
tanto anticorpos IgG anti fase I quanto anti fase II compatíveis com
febre Q crônica. Soroconversão foi detectada em 10 pacientes. A
despeito das conhecidas limitações do diagnóstico sorológico os casos
aqui relatados devem encorajar os médicos brasileiros a incluir a febre
Q como causa nativa de doença febril neste país a ser pesquisada.
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